{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:30:44Z","timestamp":1787506244694,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,7,25]],"date-time":"2007-07-25T00:00:00Z","timestamp":1185321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00347-007-1561-6","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T11:56:15Z","timestamp":1185278175000},"page":"158-164","source":"Crossref","is-referenced-by-count":32,"title":["Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD","Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD"],"prefix":"10.1007","volume":"105","author":[{"given":"D.","family":"Kook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Haritoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Ulbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,25]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD et al. (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372","journal-title":"Ophthalmology"},{"key":"1561_CR2","doi-asserted-by":"crossref","unstructured":"Bakri SJ, Patel SP (2006) Retinal pigment epithelial tear following intravitreal bevacizumab. Eye 22; Epub ahead of print","DOI":"10.1038\/sj.eye.6702700"},{"key":"1561_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00347-006-1351-6","volume":"103","author":"Bartz-Schmidt","year":"2006","unstructured":"Bartz-Schmidt KU, Holz FG (2006) Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration. Ophthalmologe 103:461\u2013462","journal-title":"Ophthalmologe"},{"key":"1561_CR4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1001\/archopht.1990.01070140048026","volume":"108","author":"Bressler","year":"1990","unstructured":"Bressler NM, Finkelstein D, Sunness JS et al. (1990) Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol 108:1694\u20131697","journal-title":"Arch Ophthalmol"},{"key":"1561_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.69.6.397","volume":"69","author":"Casswell","year":"1985","unstructured":"Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69:397\u2013403","journal-title":"Br J Ophthalmol"},{"key":"1561_CR6","first-page":"1508","volume":"113","author":"Chakravarthy","year":"2006","unstructured":"Chakravarthy U, Adamis AP, Cunningham ET Jr et al. (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113:1508.e1\u20131525","journal-title":"Ophthalmology"},{"key":"1561_CR7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archopht.1990.01070140041025","volume":"108","author":"Coscas","year":"1990","unstructured":"Coscas G, Koenig F, Soubrane G (1990) The pretear characteristics of pigment epithelial detachments: a study of 40 eyes. Arch Ophthalmol 108:1687\u20131693","journal-title":"Arch Ophthalmol"},{"key":"1561_CR8","first-page":"1001","volume":"113","author":"D","year":"2006","unstructured":"D\u2019Amico DJ VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B (2006) Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113:1001.e1\u20131006","journal-title":"Ophthalmology"},{"key":"1561_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2005.10.053","volume":"141","author":"Dhalla","year":"2006","unstructured":"Dhalla MS, Blinder KJ, Tewari A et al. (2006) Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 141:752\u2013754","journal-title":"Am J Ophthalmol"},{"key":"1561_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.iae.0000244722.35073.7c","volume":"26","author":"Freeman","year":"2006","unstructured":"Freeman WR, Falkenstein I (2006) Avastin and new treatments for AMD: where are we? Retina 26: 853\u2013858","journal-title":"Retina"},{"key":"1561_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bjo.68.8.513","volume":"68","author":"Gass","year":"1984","unstructured":"Gass JDM (1984) Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 68:513\u2013519","journal-title":"Br J Ophthalmol"},{"key":"1561_CR12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0002-9394(84)90684-6","volume":"98","author":"Gass","year":"1984","unstructured":"Gass JDM (1984) Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 98:700\u2013706","journal-title":"Am J Ophthalmol"},{"key":"1561_CR13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1600-0420.2006.00765.x","volume":"84","author":"Gelisken","year":"2006","unstructured":"Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU (2006) Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 84: 833\u2013834","journal-title":"Acta Ophthalmol Scand"},{"key":"1561_CR14","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr et al. (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805\u20132816","journal-title":"N Engl J Med"},{"key":"1561_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.65.6.417","volume":"65","author":"Hoskin","year":"1981","unstructured":"Hoskin A, Bird AC, Sehmi K (1981) Tears of detached retinal pigment epithelium. Br J Ophthalmol 65: 417\u2013422","journal-title":"Br J Ophthalmol"},{"key":"1561_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-2005-858231","volume":"222","author":"Jaissle","year":"2005","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt, KU (2005) Empfehlung f\u00fcr die Durchf\u00fchrung von intravitrealen Injektionen. Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbandes der Augen\u00e4rzte Deutschlands (BVA). Klin Monatsbl Augenheilkd 222:390\u2013395","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1561_CR17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9394(85)90626-9","volume":"100","author":"Krishnan","year":"1985","unstructured":"Krishnan NR, Chandra SR, Stevens TS (1985) Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol 100:698\u2013707","journal-title":"Am J Ophthalmol"},{"key":"1561_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00347-006-1352-5","volume":"103","author":"Ladewig","year":"2006","unstructured":"Ladewig MS, Ziemssen F, Jaissle G et al. (2006) Intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmologe 103:463\u2013470","journal-title":"Ophthalmologe"},{"key":"1561_CR19","doi-asserted-by":"crossref","unstructured":"Mennel S, Callizo J, Schmidt JC, Meyer CH (2007) Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin trademark) injections. Acta Ophthalmol Scand Apr 2; [Epub ahead of print]","DOI":"10.1111\/j.1600-0420.2007.00926.x"},{"key":"1561_CR20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bjo.2006.093732","volume":"90","author":"Meyer","year":"2006","unstructured":"Meyer CH, Mennel S, Schmidt JC, Kroll P (2006) Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 90:1207\u20131208","journal-title":"Br J Ophthalmol"},{"key":"1561_CR21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajo.2005.08.046","volume":"141","author":"Michels","year":"2006","unstructured":"Michels S, Aue A, Simader C et al. (2006) Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 141: 396\u2013398","journal-title":"Am J Ophthalmol"},{"key":"1561_CR22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","volume":"112","author":"Michels","year":"2005","unstructured":"Michels S, Rosenfeld PJ, Puliafito CA et al. (2005) Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112:1035\u20131047","journal-title":"Ophthalmology"},{"key":"1561_CR23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/112067210601600521","volume":"16","author":"Nicolo","year":"2006","unstructured":"Nicolo M, Ghiglione D, Calabria G (2006) Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 16:770\u2013773","journal-title":"Eur J Ophthalmol"},{"key":"1561_CR24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/112067210601600221","volume":"16","author":"Panagiotidis","year":"2006","unstructured":"Panagiotidis D, Karagiannis DA, Baltatzis S (2006) Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 16:326\u2013329","journal-title":"Eur J Ophthalmol"},{"key":"1561_CR25","doi-asserted-by":"crossref","unstructured":"Pauleikhoff D, L\u00f6ffert D, Spital G et al. (2002) Pigment epithelial detachment in the elderly. Graefe\u2019s Arch Clin Exp Ophthalmol 240:533\u2013538","DOI":"10.1007\/s00417-002-0505-8"},{"key":"1561_CR26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00006982-200112000-00017","volume":"21","author":"Pece","year":"2001","unstructured":"Pece A, Introini U, Bottoni F et al. (2001) Acute retinal pigment epithelial tear after photodynamic therapy. Retina 21:661\u2013665","journal-title":"Retina"},{"key":"1561_CR27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2006.01.027","volume":"113","author":"Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Heier JS, Hantsbarger G et al. (2006) Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 113: 623\u2013632","journal-title":"Ophthalmology"},{"key":"1561_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0002-9394(89)90861-1","volume":"108","author":"Schoeppner","year":"1989","unstructured":"Schoeppner G, Chuang EL, Bird AC (1989) The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol 108:683\u2013685","journal-title":"Am J Ophthalmol"},{"key":"1561_CR29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00347-006-1418-4","volume":"103","author":"Schrader","year":"2006","unstructured":"Schrader WF (2006) Age-related macular degeneration: a socioeconomic time bomb in our aging society. Ophthalmologe 103:742\u2013748","journal-title":"Ophthalmologe"},{"key":"1561_CR30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajo.2006.07.037","volume":"142","author":"Shah","year":"2006","unstructured":"Shah CP, Hsu J, Garg SJ et al. (2006) Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142:1070\u20131072","journal-title":"Am J Ophthalmol"},{"key":"1561_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2006.03.051","volume":"142","author":"Singh","year":"2006","unstructured":"Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160\u2013162","journal-title":"Am J Ophthalmol"},{"key":"1561_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","volume":"26","author":"Spaide","year":"2006","unstructured":"Spaide RF, Laud K, Fine HF et al. (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383\u2013390","journal-title":"Retina"},{"key":"1561_CR33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2006.06.048","volume":"142","author":"Spandau","year":"2006","unstructured":"Spandau UH, Jonas JB (2006) Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 142: 1068\u20131070","journal-title":"Am J Ophthalmol"},{"key":"1561_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00006982-200210000-00027","volume":"22","author":"Srivastava","year":"2002","unstructured":"Srivastava SK, Sternberg P Jr (2002) Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia. Retina 22:669\u2013671","journal-title":"Retina"},{"key":"1561_CR35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00347-006-1356-1","volume":"103","author":"V\u00f6lker","year":"2006","unstructured":"V\u00f6lker M, Peters S, Inhoffen W et al. (2006) Early antiexudative response OCT monitoring after intravitreal bevacizumab injection. Ophthalmologe 103: 476\u2013483","journal-title":"Ophthalmologe"},{"key":"1561_CR36","first-page":"8","volume":"95","author":"Yeo","year":"1988","unstructured":"Yeo JH, Marcus S, Murphy RP (1988) Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 95:8\u201313","journal-title":"Ophthalmology"},{"key":"1561_CR37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3928\/1542-8877-20030501-12","volume":"34","author":"Yoshitani","year":"2003","unstructured":"Yoshitani S, Katsura M, Minamoto A et al. (2003) Retinal pigment epithelial tear involving the fovea with preserved visual function. Ophthalmic Surg Lasers Imaging 34:217\u2013220","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1561_CR38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00347-006-1354-3","volume":"103","author":"Ziemssen","year":"2006","unstructured":"Ziemssen F, Bartz-Schmidt KU, Grisanti S (2006) (Side) effects of VEGF inhibition. Ophthalmologe 103:484\u2013492","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-007-1561-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1561-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T09:23:32Z","timestamp":1629451412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-007-1561-6"}},"subtitle":["H\u00e4ufigkeit und Verlauf","Frequency and progress"],"short-title":[],"issued":{"date-parts":[[2007,7,25]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s00347-007-1561-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,25]]}}}